Based on news reporting.
Bristol-Myers Squibb Company (BMS) has announced plans to enhance its cost-cutting measures by adding $2 billion to its existing budget. This decision comes in the wake of the successful launch of its new drug, Cobenfy, and reflects the company's strategic shift towards optimizing operations and exploring potential deals. While specific details regarding employee layoffs were not disclosed, the company is expected to implement significant workforce adjustments as part of its restructuring efforts. The exact timeline and number of positions affected remain unclear, but the move indicates a proactive approach to streamline operations in a competitive market.
LayoffTalk has tracked 27 layoff events at Bristol-Myers Squibb Company since October 2023, affecting a combined 7,522 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
Bristol-Myers Squibb Company has announced planned job cuts. If you work there, what are you hearing internally? Which teams expect to be affected? You can post anonymously below.
Estimated figure based on news reporting. Not yet confirmed by Bristol-Myers Squibb Company.
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.